首页/数据集/Perspective on this Article from High-Dose Fenretinide in Oral Leukoplakia

Perspective on this Article from High-Dose Fenretinide in Oral Leukoplakia

Figshare2009-01-01 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Perspective_on_this_Article_from_High-Dose_Fenretinide_in_Oral_Leukoplakia/22523041 数据链接链接失效反馈

官方服务：

资源简介：

Perspective on this Article from High-Dose Fenretinide in Oral Leukoplakia

应用场景：

创建时间：

2009-01-01

器官芯片

药物临床前评价

Supplementary material. Autologous iPSC-derived four-organ-chip – KeyGene counts Microphysiological systems play a pivotal role in progressing towards a global paradigm shift in drug development. H

DataCite Commons2024-05-17 更新80

Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles

纳米药物递送

口腔癌治疗

Oral cancer is a common life-threatening malignancy having high mortality and morbidity rates. During the treatment process, individuals unavoidably experience severe side effects. It is essential to

DataCite Commons2024-05-17 更新30

5 Day Oral Study of A-988679 in Male Sprague Dawley Rats

药物临床前评价

毒理学实验

5 Day Oral Study of A-988679 in Male Sprague Dawley Rats

ChEBI2012-07-23 更新10

Squamous cell carcinoma of the tongue in patients older than 45 years

鳞状细胞癌临床病理

口腔癌治疗

Abstract: This study aims to evaluate the clinicopathological features, TNM status, AJCC staging and behavior of squamous cell carcinoma of the tongue (SCCT) in patients older than 45 years. The files

NIAID Data Ecosystem40

A novel irreversible TEAD inhibitor, SWTX-143, blocks the Hippo pathway and causes tumor regression in preclinical mesothelioma models. A novel irreversible TEAD inhibitor, SWTX-143, blocks the Hippo pathway and causes tumor regression in preclinical mesothelioma models

肿瘤靶向治疗

药物临床前评价

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

NIAID Data Ecosystem20